WILLIAM HOLDER: Open Payments
NPI 1205178738 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 28 payments from 10 companies in 2025. Trend: 2023 $58 · 2024 $393 · 2025 $1,448
Travel & lodging: $861Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $861 |
| ABBVIE INC. | 12 | $213 |
| ANI Pharmaceuticals, Inc. | 3 | $87 |
| Eisai Inc. | 3 | $66 |
| UCB, Inc. | 2 | $55 |
| Neurocrine BioSciences, Inc. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Genentech USA, Inc. | 1 | $31 |
| Averitas Pharma Inc. | 1 | $26 |
| Amgen Inc. | 1 | $18 |
Products named: QULIPTA, PURIFIED CORTROPHIN GEL, Leqembi, Zilbrysq, INGREZZA, BOTOX, KESIMPTA, UBRELVY.
Industry payments across AZ — which companies pay providers there.
